PHILADELPHIA--(BUSINESS WIRE)--Avid Radiopharmaceuticals, Inc., a leader in the development of products with the potential for earlier and more effective detection, diagnosis, and monitoring of brain disorders, today announced that Daniel M. Skovronsky, M.D., Ph.D., Founder and CEO, will present at the J.P. Morgan 28th Annual Healthcare Conference.
